acetohydroxamic acid,
Lithostat,
N-hydroxyacetamide,
N-hydroxyacetamidine,
Uronefrex,
N-Hydroxyacetamidine,
22059-22-9,
N'-Hydroxyacetimidamide,
Methylamidoxime,
ACETAMIDE, OXIME,
(1Z)-N'-hydroxyethanimidamide,
Oximinoacetamide,
(E)-N'-hydroxyacetimidamide,
N-Hydroxy-acetamidine,
N'-hydroxyethanimidamide,
N-Hydroxyethanimidamide,
1429624-21-4,
BRN 0605364,
Acetamide oxime, 95+%,
N'-Hydroxyacetamidine,
Ethanimidamide, N-hydroxy-,
N-HYDROXYACETIMIDAMIDE,
acetamidoxim,
117771-39-8,
Acetamidoxime (8CI),
AC1NUPR0,
AC1Q2A2N,
(Z)-N'-hydroxyethanimidamide,
(Z)-N'-hydroxyethenimidamide,
DTXSID70176544,
ALBB-009731,
Ethanimidamide, N-hydroxy- (9CI),
BBL005334,
MFCD00506021,
MFCD00603514,
STK500696,
AKOS000278505,
AKOS024437710,
AB06530,
AS-5562,
CS-W008635,
MCULE-5595239824,
RTR-010385,
LS-10084,
SC-29589,
AB0002451,
AB1004386,
TC-136867,
TR-010385,
BB 0241915,
ST24031219,
W4551,
H15978,
M-9117,
4-02-00-00433 (Beilstein Handbook Reference),
S14-2933,
F2158-1153,
Acetamidoxime,
N-Hydroxyacetamide,
ACETAMIDE OXIME,
(Z)-N'-hydroxyacetimidamide,
C2H6N2O,
Acetamide oxime, 98% - 1G 1g,
CID5487681,